June 2025 - Page 6 of 8 - NetworkNewsWire

MondayJun 09, 2025 1:00 pm

Nightfood Holdings Inc. (NGTF) Expands Hospitality Automation with Strategic Hotel Acquisitions

$36.93M LOI signed to acquire Hilton Garden Inn in Rancho Mirage, California, next to Disney’s Cotino development Follows $41M deal for Victorville Holiday Inn, set to become a model for robotics-enabled hotel operations Recently acquired Future Hospitality Ventures (which holds an exclusive U.S. partnership with Bear Robotics) and the addition of Skytech Automated Solutions - both aimed at expanding its AI-powered robotics initiatives in the hospitality industry The combined value of these acquisitions is expected to strengthen the positioning of the company for a successful uplisting, unlocking the full range of benefits associated with national exchange As automation reshapes hospitality,…

MondayJun 09, 2025 12:15 pm

Brera Holdings PLC (NASDAQ: BREA) and Toronto Blizzard Partner to Build Global Youth Soccer Pipeline

Brera Holdings and Toronto Blizzard are launching a grassroots soccer initiative focused on player development across North America and three continents. The partnership draws on Blizzard’s past collaboration with Bundesliga champions FC Bayern Munich to develop a training model for young players. The program targets children as young as three, with development pathways extending into Brera’s professional clubs in Italy, North Macedonia, Mongolia, and Mozambique. Toronto Blizzard’s longtime owner-coach Giuseppe “Joe” Parolini has been appointed Brera’s Academy Sports Director for North America. Talent identification camps in Canada and training stints at European academies are expected to begin by summer 2026.…

MondayJun 09, 2025 11:30 am

The Alternative Products Expo Nashville Everything the Counterculture Industry Has to Offer

The Alternative Products Expo is proud to announce the Nashville edition of its industry-leading expo. Carrying on a legacy running since 2017, the expo offers manufacturers, retailers, enthusiasts, and entrepreneurs a platform to showcase everything the counterculture industry offers, for today and tomorrow. Participating brands will be among the first to tap into the emerging market and build brand recognition at the expo. They will also be able to capitalize on growth and profitability while positioning themselves as leaders in a rapidly evolving market. Previous Alternative Products Expos have attracted a wide range of participants, from manufacturers to individuals in…

FridayJun 06, 2025 12:45 pm

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Stands Out in Booming Gold Market, Offers Strategic Investment Avenue

The gold market's current dynamics underscore the metal's enduring appeal Lahontan Gold boasts a portfolio of four gold and silver projects located in Nevada's prolific Walker Lane LGCXF’s management team comprises seasoned professionals with extensive experience in mineral exploration, project development and corporate finance LGCXF recently named as “one of the best gold developers in Nevada” In an era marked by economic volatility and geopolitical tensions, gold has reasserted itself as a premier safe-haven asset. Gold prices have soared to unprecedented levels, surpassing $3,400 per ounce, driven by factors such as trade disputes, inflationary pressures and global uncertainty (https://nnw.fm/xZ4nZ). This bullish…

FridayJun 06, 2025 12:00 pm

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances

The company’s non-invasive fingerprint drug screening system uses fingerprint sweat to screen for drugs such as cannabis, cocaine, methamphetamine, and opiates. Results are available in under ten minutes, supporting faster, on-site decision-making in treatment and justice settings. INBS is pursuing FDA approval and further entry into the U.S. market, where it currently operates in a Forensic Use Only capacity. The company has over 450 active accounts in 24 countries, targeting sectors such as healthcare, justice, and workplace safety. INBS partnered with SMARTOX, a U.S. distributor, to connect with stakeholders in criminal justice and addiction recovery. Intelligent Bio Solutions (NASDAQ: INBS),…

FridayJun 06, 2025 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Tests Potential for Streamlining Tailings Process, Offering Important Cost and Environment Benefits

ESGold is a gold and silver company preparing for production later this year at a tailings reclamation site in Quebec abandoned by the previous operator The gold and silver resource developer expects to concentrate on reprocessing the tailings for the near-term to extract mica and any remaining gold and silver, anticipating that the resulting mica concentrate will be useful in a wide variety of building and roadwork materials ESGold plans to build revenue through the reuse project, which can then help fund planned exploration at its Quebec property covering 13,116 hectares (about 32,410 acres) The company is currently conducting testing…

FridayJun 06, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting CTCL

Soligenix’s HyBryte(TM) is a photodynamic therapy using synthetically manufactured hypericin, one of the most photoactive compounds available. The therapeutic potential of HyBryte(TM) has been demonstrated through multiple clinical trials, including a Phase 3 trial in early-stage CTCL patients. HyBryte(TM) has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and the European Medicines Agency. Cutaneous T-cell lymphoma (“CTCL”) is a rare and debilitating form of non-Hodgkin’s lymphoma that primarily affects the skin, posing both physical and emotional challenges for those diagnosed. With limited treatment options available and no definitive cure, the need for innovative, safe and effective…

ThursdayJun 05, 2025 11:15 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a planned national clinic network, and is expected to immediately improve revenue and EBITDA for NRx and HOPE Therapeutics. HOPE aims to develop a network of up to 30 interventional psychiatry clinics by the end of 2025, with a $100 million pro forma run rate by YE 25. Kadima specializes in interventional psychiatry, and Kadima’s founder Dr. David Feifel, will join HOPE as Chief Medical Innovation Officer. NRx’s broader pipeline includes FDA-designated treatments for bipolar depression and acute suicidality. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical…

ThursdayJun 05, 2025 10:30 am

Nightfood Holdings Inc. (NGTF) Taps Proven Leaders to Accelerate Hospitality Innovation

Nightfood Holdings new executives have strong track records in a variety of spaces NGTF's new leadership team is poised to leverage their combined expertise to facilitate the company's growth and innovation The foundation of any successful company often rests on the quality and vision of its leadership. Experienced executives can be the deciding factor between stagnation and rapid growth, particularly in dynamic sectors such as consumer goods and hospitality. That’s why Nightfood Holdings (OTCQB: NGTF) made waves recently with its announcement of new senior leadership appointments aimed at accelerating innovation and expansion across its growing portfolio of hospitality-focused services. According…

ThursdayJun 05, 2025 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology

Buprenorphine is a medication approved by the U.S. Food and Drug Administration (“FDA”) to treat opioid use disorder and chronic and severe pain Nutriband is developing a novel transdermal delivery system for buprenorphine, projected to reach peak annual sales of $70M - $130M The company’s AVERSA pipeline currently includes two main candidates: AVERSA(TM) Fentanyl and AVERSA(TM) Buprenorphine As the opioid epidemic continues to pose one of the most critical public health crises in the United States and around the world, the need for innovative, safer treatments has never been more urgent. One company, Nutriband (NASDAQ: NTRB), is aiming to transform how opioid-based therapies are administered and protected…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: June 2025